Artificial intelligence in a primary care and clinic settings increases the likelihood of catching diabetic retinopathy in underinsured patients, resulting in increased successful referrals.
Modern Retina Winter 2022
Being able to visualize and evaluate the retinal periphery provides a better understanding of the disease status and supports a better treatment decision.
OPT-302 in combination with standard-of-care anti-VEGF-A agents shown to improve visual acuity, anatomic endpoints.
Advertisement
Advertisement
Trending on Modern Retina
1
Dompé's NAION program selected for FDA Commissioner’s National Priority Voucher Program
2
FDA approves Glaukos’ Epioxa incision-free keratoconus therapy
3
Current and Emerging Treatments for Geographic Atrophy and When to Initiate Therapy
4
